SUCLA2 and cancer: Given the critical role of glutaminolysis in many types of cancer progression, the discovery of SUCLA2-coupled regulation of GLS succinylation in precise regulation of glutaminolysis provides GLS succinylation as a novel and promising diagnostic and therapeutic target for cancer care.